Intravenous drug use is the single largest exposure category among women with AIDS in the United States (51%). Tragically, there may be insufficient appreciation of the issues unique to IV drug usage among women.
Few drug treatment programs are specifically designed for women, and fewer still are aimed at HIV positive women.
Treatment models relevant to women in light of the AIDS epidemic should: include changes in admission criteria and treatment methods.
Mots-clés Pascal : Toxicomanie, Voie intraveineuse, Femme, Homme, Facteur risque, Immunodéficit acquis syndrome, Virose, Infection, Immunopathologie, Hémopathie, Programme sanitaire, Prévention, Organisation santé
Mots-clés Pascal anglais : Drug addiction, Intravenous administration, Woman, Human, Risk factor, AIDS, Viral disease, Infection, Immunopathology, Hemopathy, Sanitary program, Prevention, Public health organization
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 92-0323467
Code Inist : 002B18C05. Création : 199406.